Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2 expression

Yu,Boshi; Li,Mengmeng; Han,Shu Ping; Yu,Zhangbin; Zhu,Jingai

doi:10.3892/mmr.2021.12501

Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2 expression

Authors:
- Boshi Yu
- Mengmeng Li
- Shu Ping Han
- Zhangbin Yu
- Jingai Zhu
View Affiliations

Affiliations: Department of Pediatrics, Women's Hospital of Nanjing Medical University Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu 210004, P.R. China
Published online on: October 19, 2021 https://doi.org/10.3892/mmr.2021.12501
Article Number: 861
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previously it was found that hsa_circ_105039 was underexpressed in the heart tissue of patients with congenital heart disease (CHD). However, the function and mechanism of hsa_circ_105039 in CHD are unclear. In the present study, induced pluripotent stem (iPS) cells were differentiated into cardiomyocytes using 1% dimethyl sulfoxide (DMSO). Cell differentiation, viability, migration and apoptosis were measured before and following hsa_circ_105039 knockdown or overexpression. The results indicated that hsa_circ_105039 overexpression promoted cell differentiation, viability and migration; whereas apoptosis was simultaneously repressed. A luciferase reporter assay verified that hsa_circ_105039 acted as a sponge for microRNA (miR)‑17 and that cyclinD2 was a direct target of miR‑17. Furthermore, differentiation‑related genes and proteins were analyzed by reverse transcription‑quantitative PCR and western blotting, respectively. The results showed that hsa_circ_105039 could also upregulate the expression of differentiation‑related genes and proteins, including natriuretic peptide A, cardiac troponin I, GATA‑binding protein 4 and homobox transcription factor, in iPS cells. The results suggested that hsa_circ_105039 exerted a protective effect by promoting miR‑17/cyclinD2 in DMSO‑induced iPS cardiomyocytes, which indicated that hsa_circ_105039 is a potential key molecule for the diagnosis of CHD.

View Figures

View References

1	Fernandes SM, Marelli A, Hile DM and Daniels CJ: Access and delivery of adult congenital heart disease care in the United States: Quality driven team based care. Cardiol Clin. 38:295–304. 2020. View Article : Google Scholar : PubMed/NCBI
2	Burchill LJ, Lee MGY, Nguyen VP and Stout KK: Heart failure in adult congenital heart disease. Cardiol Clin. 38:457–469. 2020. View Article : Google Scholar : PubMed/NCBI
3	Schulkey CE, Regmi SD, Magnan RA, Danzo MT, Luther H, Hutchinson AK, Panzer AA, Grady MM, Wilson DB and Jay PY: The maternal-age-associated risk of congenital heart disease is modifiable. Nature. 520:230–233. 2015. View Article : Google Scholar : PubMed/NCBI
4	Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ, Lemke K, Chen Y, Chatterjee B, Devine W, Damerla RR, et al: Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature. 521:520–524. 2015. View Article : Google Scholar : PubMed/NCBI
5	Bruneau BG: The developmental genetics of congenital heart disease. Nature. 451:943–948. 2008. View Article : Google Scholar : PubMed/NCBI
6	Sakhi R, Kauling RM, Theuns DA, Szili-Torok T, Bhagwandien RE, van den Bosch AE, Cuypers JAAE, Roos-Hesselink JW and Yap SC: Early detection of ventricular arrhythmias in adults with congenital heart disease using an insertable cardiac monitor (EDVA-CHD study). Int J Cardiol. 305:63–69. 2020. View Article : Google Scholar : PubMed/NCBI
7	Meller CH, Grinenco S, Aiello H, Córdoba A, Sáenz-Tejeira MM, Marantz P and Otaño L: Congenital heart disease, prenatal diagnosis and management. Arch Argent Pediatr. 118:e149–e161. 2020.(In English, Spanish). PubMed/NCBI
8	Bishop L, Lansbury A and English K: Adult congenital heart disease and pregnancy. BJA Educ. 18:23–29. 2018. View Article : Google Scholar : PubMed/NCBI
9	Shum KK, Gupta T, Canobbio MM, Durst J and Shah SB: Family planning and pregnancy management in adults with congenital heart disease. Prog Cardiovasc Dis. 61:336–346. 2018. View Article : Google Scholar : PubMed/NCBI
10	Schmidt AB, Lund M, Corn G, Halldorsson TI, Øyen N, Wohlfahrt J, Olsen SF and Melbye M: Dietary glycemic index and glycemic load during pregnancy and offspring risk of congenital heart defects: A prospective cohort study. Am J Clin Nutr. 111:526–535. 2020. View Article : Google Scholar : PubMed/NCBI
11	Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
12	Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature. 495:384–388. 2013. View Article : Google Scholar : PubMed/NCBI
13	Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
14	Costello A, Lao NT, Barron N and Clynes M: Reinventing the wheel: Synthetic circular RNAs for mammalian cell engineering. Trends Biotechnol. 38:217–230. 2020. View Article : Google Scholar : PubMed/NCBI
15	Verduci L, Strano S, Yarden Y and Blandino G: The circRNA-microRNA code: Emerging implications for cancer diagnosis and treatment. Mol Oncol. 13:669–680. 2019. View Article : Google Scholar : PubMed/NCBI
16	Zhang Z, Yang T and Xiao J: Circular RNAs: Promising biomarkers for human diseases. EBioMedicine. 34:267–274. 2018. View Article : Google Scholar : PubMed/NCBI
17	Bolha L, Ravnik Glavac M and Glavac D: Circular RNAs: Biogenesis, function, and a role as possible cancer biomarkers. Int J Genomics. 2017:62183532017. View Article : Google Scholar : PubMed/NCBI
18	Huang Y, Zhang C, Xiong J and Ren H: Emerging important roles of circRNAs in human cancer and other diseases. Genes Dis. 8:412–423. 2020. View Article : Google Scholar : PubMed/NCBI
19	Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008. View Article : Google Scholar : PubMed/NCBI
20	Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R and Olson EN: MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22:3242–3254. 2008. View Article : Google Scholar : PubMed/NCBI
21	Wu J, Li J, Liu H, Yin J, Zhang M, Yu Z and Miao H: Circulating plasma circular RNAs as novel diagnostic biomarkers for congenital heart disease in children. J Clin Lab Anal. 33:e229982019. View Article : Google Scholar : PubMed/NCBI
22	Clavijo PE, Friedman J, Robbins Y, Moore EC, Smith E, Zauderer M, Evans EE and Allen CT: Semaphorin4D inhibition improves response to immune-checkpoint blockade via attenuation of MDSC recruitment and function. Cancer Immunol Res. 7:282–291. 2019. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Wada N, Wang B, Lin NH, Laslett AL, Gronthos S and Bartold PM: Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. J Periodontal Res. 46:438–447. 2011. View Article : Google Scholar : PubMed/NCBI
25	Rowntree RK and McNeish JD: Induced pluripotent stem cells: Opportunities as research and development tools in 21st century drug discovery. Regen Med. 5:557–568. 2010. View Article : Google Scholar : PubMed/NCBI
26	Casiraghi A, Ardovino P, Minghetti P, Botta C, Gattini A and Montanari L: Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents. Arch Dermatol Res. 299:201–207. 2007. View Article : Google Scholar : PubMed/NCBI
27	Santos NC, Figueira-Coelho J, Martins-Silva J and Saldanha C: Multidisciplinary utilization of dimethyl sulfoxide: Pharmacological, cellular, and molecular aspects. Biochem Pharmacol. 65:1035–1041. 2003. View Article : Google Scholar : PubMed/NCBI
28	Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J and Gepstein L: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 108:407–414. 2001. View Article : Google Scholar : PubMed/NCBI
29	Inamdar MS, Venu P, Srinivas MS, Rao K and VijayRaghavan K: Derivation and characterization of two sibling human embryonic stem cell lines from discarded grade III embryos. Stem Cells Dev. 18:423–433. 2009. View Article : Google Scholar : PubMed/NCBI
30	Pal R, Mamidi MK, Das AK and Bhonde R: Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells. Arch Toxicol. 86:651–661. 2012. View Article : Google Scholar : PubMed/NCBI
31	Behrens AN, Iacovino M, Lohr JL, Ren Y and Martin CM: Nkx2 5 mediates differential cardiac differentiation through interaction with Hoxa10. Stem Cells Dev. 22:2211–2220. 2013. View Article : Google Scholar : PubMed/NCBI
32	Cao N, Huang Y, Zheng J, Spencer CI, Zhang Y, Fu JD, Nie B, Xie M, Zhang M, Wang H, et al: Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science. 352:1216–1220. 2016. View Article : Google Scholar : PubMed/NCBI
33	Wang Z and Huang J: Neuregulin-1 increases connexin-40 and connexin-45 expression in embryonic stem cell-derived cardiomyocytes. Appl Biochem Biotechnol. 174:483–493. 2014. View Article : Google Scholar : PubMed/NCBI
34	Behrens AN, Iacovino M, Lohr JL, Ren Y, Zierold C, Harvey RP, Kyba M, Garry DJ and Martin CM: Nkx2-5 mediates differential cardiac differentiation through interaction with Hoxa10. Stem Cells Dev. 22:2211–2220. 2013. View Article : Google Scholar : PubMed/NCBI
35	Cao N, Huang Y, Zheng J, Spencer CI, Zhang Y, Fu JD, Nie B, Xie M, Zhang M, Wang H, et al: Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science. 352:1216–1220. 2016. View Article : Google Scholar : PubMed/NCBI
36	Solé C and Lawrie CH: Circular RNAs and cancer: Opportunities and challenges. Adv Clin Chem. 99:87–146. 2020. View Article : Google Scholar : PubMed/NCBI
37	Sucharov CC, Miyamoto SD and Garcia AM: Circulating microRNAs as biomarkers in pediatric heart diseases. Prog Pediatr Cardiol. 49:50–52. 2018. View Article : Google Scholar : PubMed/NCBI
38	Kandettu A, Radhakrishnan R, Chakrabarty S, Sriharikrishnaa S and Kabekkodu SP: The emerging role of miRNA clusters in breast cancer progression. Biochim Biophys Acta Rev Cancer. 1874:1884132020. View Article : Google Scholar : PubMed/NCBI
39	Wu KJ: The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness. Biomedical Journal. 43:107–114. 2020. View Article : Google Scholar : PubMed/NCBI
40	Tesfaye AA, Azmi AS and Philip PA: miRNA and gene expression in pancreatic ductal adenocarcinoma. Am J Pathol. 189:58–70. 2019. View Article : Google Scholar : PubMed/NCBI